Xiangling Wang, MD, PhD of Mayo Clinic in Rochester, MN was honored as the 2014-2015 recipient of the Pfizer/ACMG Foundation Clinical Genetics Combined Residency for Translational Genomic Scholars Fellowship Award at the ACMG 2014 Annual Clinical Genetics Meeting in Nashville, TN.
The objective of this award is to advance education, research and standards of practice in medical genetics; to develop and expand clinical and laboratory expertise in medical genetics in the United States; and to initiate and develop a broad-based infrastructure for industry funding of high quality projects in the fields of medical genetics. Dr. Wang will be given the opportunity to participate in an in-depth clinical and research experience at a premier medical center with expertise and significant clinical volume in the area of translational genomics.
This Award grants $75,000 per year to the recipient selected by the ACMG Foundation through a competitive process and will provide for the sponsorship of one year of the trainee's clinical genetics subspecialty in translational genomics following residency.
Dr. Wang received her MD at Shandong Medical University (currently School of Medicine, Shandong University), Jinan, China, her PhD in Medicine/Nephrology at the School of Medicine, Shanghai JiaoTong University, Shanghai, China and is currently in her first year of residency in Medical Genetics at the Mayo Clinic, Rochester, MN. Her research during the award period will focus on exposure to the diagnosis and management of patients with lysosomal storage diseases (LSDs) and the training and involvement in the clinical trials including course work and research projects in collaboration with the Center of Clinical Translational Activities (CTSA) at Mayo Clinic.
"I am honored and proud to receive the Pfizer/ACMG Foundation award. I want to personally thank the Medical Genetics Residency Program at Mayo Clinic that provides me with such an excellent educational and research environment. I will work hard to achieve all the proposed goals. I believe the training under this award will make me ready for my future academic career with a research focus on lysosomal storage diseases. It is my hope that I can better serve my patients in the future and contribute to making a difference in the day-to-day lives of those who suffer with lysosomal storage diseases."
"Recent advances in genomics present great opportunities to develop new approaches to diagnosis and treatment of genetic disorders. The Pfizer/ACMG Foundation Clinical Genetics Combined Residency for Translational Genomic Scholars provides a wonderful opportunity to train physician scientists to be leaders in translational research in medical genomics," said Bruce R. Korf, MD, PhD, FACMG, president of the ACMG Foundation.
|Contact: Kathy Beal|
American College of Medical Genetics